Furthermore, inactivating the VHL mutation is considered a prevalent risk factor to ccRCC [7], and the dysfunction of VHL promotes neovascularization, which mediated the activation of the HIF/VEGF axis [8]. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.